An eHealth company building a platform for real-world patient insights, XO Life has closed a $4.7M seed funding round. The capital infusion will support its mission to establish digital treatment monitoring and patient feedback as the industry standard for pharmaceutical R&D, marketing, and sales.
XO Life's solution facilitates real-time information exchange between patients and pharma, leveraging scientifically based questionnaires to gather long-term data across various treatments and indications. This approach helps the pharmaceutical industry gain a deeper understanding of its patients, all while adhering to stringent data protection and security standards.
